MedPage Today on MSN
Similar prostate cancer drugs show different results in real-world study
Better short-term survival with apalutamide versus darolutamide, but lots of unanswered qu ...
As we gear up to observe World Cancer Day 2026 under the theme 'United by Unique', let's take a look at the stages of ...
K36 Therapeutics, Inc. ("K36"), a privately held clinical-stage biotechnology company developing novel targeted therapies for ...
Men such as Tony Webber have limited, and expensive, treatment options for advanced prostate cancer. A new program aims to improve outcomes and dares to mention the word ‘cure’ for some.
On World Cancer Day 2026, oncologists spoke about the early signs of prostate cancer, which are often mistaken for ...
Recently, the research team led by Professor Jun Pang from the Department of Urology at The Seventh Affiliated Hospital of Sun Yat-sen University discovered that cyclin-dependent kinase 12 (CDK12) can ...
A real-world study found Erleada reduced the risk of death compared with Nubeqa in patients with metastatic ...
Tolmar, Inc. today announced the launch of Care Partner Corner ( a comprehensive digital resource created specifically to support and empower care partners of prostate cancer patients. This free, easy ...
A cancer specialist explains the subtle warning signs that are easy to dismiss ...
The New Times on MSN
Early screening saved my life: Prostate cancer survivor, 77, urges men to test early
Jacques Mbalirende, 77, a father of four from Kigali’s suburb of Nyamirambo, is a prostate cancer survivor who was diagnosed in 2017 after a routine checkup led to further testing. ALSO READ: Men over ...
Medical experts say knowing your body and keeping up with routine screenings are the most effective ways to catch cancer ...
A new study from The University of Texas MD Anderson Cancer Center has found that treating prostate cancer early, before it spreads widely, can make a big difference. The research, published in The ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果